Showing results (131-140 of 182) with videos related to
Sort By:
Pageof 19
Annals of Clinical and Translational Neurology|August 29, 2025
Real World Effectiveness and Tolerability of Novel Monoclonal Antibodies and Rituximab for NMOSDZarmina Javed, Mengke Du, Mary Rensel, et al.Journal of Visualized Experiments : Jove|August 6, 2019
Comprehensive Autopsy Program for Individuals with Multiple SclerosisRanjan Dutta, Kedar R Mahajan, Kunio Nakamura, et al.Neuroimage|December 5, 2025
Efficient Whole-Brain Quantitative Magnetization Transfer Imaging at 3T Using Segmented EPI Readout with Variable Power Magnetization Transfer Pulses (EP-vpMT)Se-Hong Oh, Ken E Sakaie, Gawon Lee, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 8, 2024
High-resolution diffusion tensor imaging of the fornix predicts memory function in multiple sclerosisKatherine A Koenig, Ken E Sakaie, Daniel Ontaneda, et al.Neurology|July 1, 2021
Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple SclerosisKarla Gray-Roncal, Kathryn C Fitzgerald, Lana Zhovtis Ryerson, et al.Neurology|January 24, 2024
Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor EncephalitisAnnalisa Morgan, Yadi Li, Nicolas R Thompson, et al.Annals of Clinical and Translational Neurology|January 22, 2024
Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disordersSanem P Uysal, Yadi Li, Nicolas R Thompson, et al.Multiple Sclerosis and Related Disorders|July 23, 2026
Tailoring disease-modifying therapy approaches across multiple sclerosis sub-populationsAlbert Aboseif, Burcu Zeydan, Nabeela Nathoo, et al.Journal of the Neurological Sciences|October 24, 2019
Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-upBrandi Vollmer, Daniel Ontaneda, Haleigh Harris, et al.Neurology. Clinical Practice|July 10, 2020
Achieving effective patient and public involvement in international clinical trials in neurologyEmma C Tallantyre, Nikos Evangelou, Clare Bale, et al.Pageof 19